The FDA approved tirzepatide in May 2022 under the brand name Mounjaro for type 2 diabetes management, and in November 2023 under the brand name Zepbound for chronic weight management in adults meeting specific BMI criteria
Research on inflammation and peptides shows that reducing visceral fat decreases systemic inflammatory signals, creating a positive feedback loop where lower inflammation further supports metabolic improvements
PlexusDx's compounded semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan), and initial consultations can be completed online from your home
Every TRT Nation tirzepatide prescription includes it as a standard part of the formulation
GLP-1RA has gained a sudden surge in popularity for its ability to trigger glycemic control, weight loss, and cardiovascular risk reduction [Reference Baggio and Drucker3Reference Taha, Yahya, Satish, Laird, Agatston and Cainzos-Achirica6]